There are 2949 resources available
224P - Neoadjuvant pyrotinib plus trastuzumab, docetaxel, and carboplatin in patients with HER2-positive early breast cancer: A single-group, multicenter, phase II study
Presenter: Zhenzhen Liu
Session: E-Poster Display
Resources:
Abstract
225P - Phase II study of pyrotinib plus albumin-bound paclitaxel and trastuzumab as neoadjuvant treatment in HER2-positive early or locally advanced breast cancer
Presenter: Ting Luo
Session: E-Poster Display
Resources:
Abstract
226P - Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study
Presenter: Chiara Molinelli
Session: E-Poster Display
Resources:
Abstract
228P - Pathologic response to neoadjuvant antiher2 therapy in HER2 equivocal overexpression with FISH amplification
Presenter: Serafin Morales
Session: E-Poster Display
Resources:
Abstract
227P - Cardiotoxicity in HER2 positive breast cancer patients treated with trastuzumab
Presenter: Mariana Lopez
Session: E-Poster Display
Resources:
Abstract
229P - Can immunogloblun -/+ steroid treatment protect trastuzumab cardiotoxicity, a rabbit model trial
Presenter: Neyran Kertmen
Session: E-Poster Display
Resources:
Abstract
230P - Pathologic response to neoadjuvant therapy in HER2 positive/oestrogen receptor positive breast cancer patients
Presenter: Ariadna Gasol Cudos
Session: E-Poster Display
Resources:
Abstract
231P - Voice analysis of cancer experiences among patients with breast cancer (VOICE-BC)
Presenter: Maria José Auil
Session: E-Poster Display
Resources:
Abstract
232P - Safety of fertility treatments in breast cancer survivors
Presenter: Margherita Condorelli
Session: E-Poster Display
Resources:
Abstract
233P - Sexual dysfunction among premenopausal breast cancer survivors
Presenter: Filipa Pontes
Session: E-Poster Display
Resources:
Abstract